PMA device
NEXUS Aortic Arch Stent Graft System
Endospan , Ltd. · Endovascular System For Treatment Of Ascending Aorta And Aortic Arch Lesions (SDZ, Class III) · First FDA decision Apr 2, 2026, newest Sep 21, 2026Aortic aneurysm and dissection
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
Breakthrough-designated
Device trials
22
Naming "NEXUS"
MAUDE reports
264
Brand "NEXUS", since 2015
PubMed studies
10,450
Mentioning "NEXUS"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing NEXUS Aortic Arch Stent Graft System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
- NEXUS Aortic Arch Stent Graft SystemPMA supplement
P250033-S004 · Decided Sep 21, 2026 · 90 days after receipt · Normal 180 Day Track
Device type: Endovascular System for Treatment of Ascending Aorta and Aortic Arch Lesions (SDZ) · Cardiology
- NEXUS Aortic Arch Stent Graft SystemPMA supplement
P250033-S002 · Decided Jul 24, 2026 · 85 days after receipt · Normal 180 Day Track No User Fee
Device type: Endovascular System for Treatment of Ascending Aorta and Aortic Arch Lesions (SDZ) · Cardiology
- NEXUS Aortic Arch Stent Graft SystemBreakthroughPMA
P250033 · Decided Apr 2, 2026 · 223 days after receipt
Device type: Endovascular System for Treatment of Ascending Aorta and Aortic Arch Lesions (SDZ) · Cardiology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "NEXUS", any status and sponsor, newest update first.
- Early Feasibility Study of NeoChord Transcatheter Mitral Repair SystemNot yet recruiting
NeoChordNot on our public-company list
NCT07912229 · 15 participants (planned) · Start Feb 20, 2027 · Primary completion Feb 20, 2029
Device: Transcatheter Chordal Repair · For: Degenerative Mitral Regurgitation; Degenerative Mitral Regurgitation (MR) Due to Leaflet Prolapse
- Evaluation of the Safety and Performance of the Novel Medtronic Experimental Automated Insulin Delivery System (NMX8) in People Living With Diabetes (NEXUS)Pivotal-lookingRecruiting
Medtronic MiniMed, Inc.Public (MDT)
NCT07227805 · 116 participants (planned) · Start Jul 19, 2026 · Primary completion Mar 17, 2027
Device: NMX8; 780G · For: Diabetes (Insulin-requiring, Type 1 or Type 2)
Sites: Antwerp, Belgium; Brussels, Belgium; Leuven, Belgium · 9 sites in all
- Development of Adaptive Deep Brain Stimulation for OCD (Phase 1a)Active, not recruiting
Baylor College of MedicineAcademic, hospital or other
NCT03457675 · 2 participants · Start Jul 11, 2018 · Primary completion Jun 2027
Device: Activa PC+S DBS implant for OCD · For: Obsessive-Compulsive Disorder
Sites: Pittsburgh, Pennsylvania; Providence, Rhode Island; Houston, Texas
19 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "NEXUS", and for the whole product code for context.
This brand
264 reports: 206 malfunction, 55 injury, 2 death
Whole product code SDZ
5 reports: 2 malfunction, 1 injury, 2 death
Newest reports for this brand
3009304068-2026-00003 · Received Oct 23, 2026 · Event dated Sep 22, 2026
Device type: Endovascular System For Treatment Of Ascending Aorta And Aortic Arch Lesions (SDZ)
Device problem as coded: Separation Failure; Detachment of Device or Device Component; Difficult to Open or Close
Patient problem as coded: Stroke/CVA
3009304068-2026-00004 · Received Oct 23, 2026 · Event dated Sep 17, 2026
Device type: Endovascular System For Treatment Of Ascending Aorta And Aortic Arch Lesions (SDZ)
Device problem as coded: Fracture; Material Separation
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
3009304068-2026-00005 · Received Oct 23, 2026 · Event dated Sep 2, 2026
Device type: Endovascular System For Treatment Of Ascending Aorta And Aortic Arch Lesions (SDZ)
Device problem as coded: Separation Failure
Patient problem as coded: Stroke/CVA
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "NEXUS"[tiab]. The summary above synthesizes these.
- Welcome, PNAS Nexus!
McNutt M · PNAS Nexus · 2022Editorial
- Introducing PNAS Nexus.
Nelson K, Foufoula-Georgiou E, Gelfand M, et al. · PNAS Nexus · 2022Editorial
- The food-climate nexus.
Nat Food · 2023Editorial
- Brain Connectivity: Embracing the Nexus of Mind and Matter.
Laureys S · Brain Connect · 2024Editorial, Introductory Journal Article
- p38α: A Profibrotic Signaling Nexus.
Stratton MS, Koch KA, McKinsey TA · Circulation · 2017Editorial, Research Support, N.I.H., Extramural
- Wastewater-Energy Nexus.
Liu Y, Yu HQ, Ng WJ, et al. · Chemosphere · 2015Editorial
- The climate change-homelessness nexus.
Kidd SA, Hajat S, Bezgrebelna M, et al. · Lancet · 2021
- Exploring the Lung-Gut Nexus.
Pande A · Chest · 2022Editorial
- Water-energy nexus.
Schnoor JL · Environ Sci Technol · 2011Introductory Journal Article
- The heterogeneity-diversity-system performance nexus.
Eisenhauer N, Angst G, Asato AEB, et al. · Natl Sci Rev · 2023Review
- The sustainability-peace nexus: why is it important?
Sharifi A, Simangan D, Kaneko S, et al. · Sustain Sci · 2021Editorial
- The Energy-Water-Food Nexus.
Keairns DL, Darton RC, Irabien A · Annu Rev Chem Biomol Eng · 2016Review
Other devices of this type
Also filed under product code SDZ.
- GORE TAG Thoracic Branch Endoprosthesis (TBE Device)W. L. Gore & Associates, Inc. · PMA 2025
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.